title: Clinical and laboratory characteristics of 144 patients with mediterranean spotted fever.
authors.affiliation: Department of Internal Medicine, Corporació Parc Taulí, Parc Taulí s/n, 08208, Sabadell, Barcelona, Spain. eanton@cspt.es
authors.forename: E
authors.initials: E
authors.lastname: Antón
authors.forename: B
authors.initials: B
authors.lastname: Font
authors.forename: T
authors.initials: T
authors.lastname: Muñoz
authors.forename: I
authors.initials: I
authors.lastname: Sanfeliu
authors.forename: F
authors.initials: F
authors.lastname: Segura
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D001907:Boutonneuse Fever / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D019411:Clinical Laboratory Techniques; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D015570:Josamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D020114:Rickettsia conorii / Q000187:drug effects / Q000302:isolation & purification*; D012307:Risk Factors; D012698:Serologic Tests / Q000379:methods; D012720:Severity of Illness Index; D017678:Sex Distribution; D013030:Spain / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D015570:Josamycin